NCT03199300View on ClinicalTrials.gov

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

February 6, 2025

Study Completion Date

January 31, 2027

Conditions
Toxicity Due to ChemotherapyCardiovascular MorbidityCancer, Treatment-Related
Interventions
DRUG

Anthracyclines

Chemotherapy regimen containing anthracyclines.

DRUG

Trastuzumab

Systemic treatment including trastuzumab.

DRUG

Cisplatin

Chemotherapy including cisplatin.

DRUG

Bleomycin

Chemotherapy including bleomycin.

Trial Locations (1)

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER